Several studies reported that wild type p53 can exert its anti-oxidant function by hampering inflammatory process through the inhibition of the activity of the transcription factor NF-κB [149,150,151], a key regulator of chemokines expression and of chronic inflammation that sustains cancer initiation and progression [152]. The gene discussed is NFKB1; the disease is cancer.